We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 258 results
  1. Emerging Applications of Hydroxypropyl Methylcellulose Acetate Succinate: Different Aspects in Drug Delivery and Its Commercial Potential

    Hydroxypropyl methylcellulose acetate succinate (HPMCAS) has multi-disciplinary applications spanning across the development of drug delivery...

    Manisha Choudhari, Shantanu Damle, ... Gautam Singhvi in AAPS PharmSciTech
    Article 15 September 2023
  2. Characterization of Grades of HPMCAS Spray Dried Dispersions of Itraconazole Based on Supersaturation Kinetics and Molecular Interactions Impacting Formulation Performance

    Purpose

    The objective was to characterize hydroxypropyl methylcellulose acetate succinate (HMPCAS) grades L, M, and H to enhance itraconazole (ITZ)...

    Asmita Adhikari, James E. Polli in Pharmaceutical Research
    Article 10 September 2020
  3. Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion

    Pretomanid (PTM), an oral antibiotic used in the treatment of adults with pulmonary extensively drug-resistant, nonresponsive multidrug-resistant...

    Mehak Juneja, Krishna Mehtre, ... Abhay T. Sangamwar in Drug Delivery and Translational Research
    Article 05 June 2024
  4. Development of Delayed Release Oral Formulation Comprising Esomeprazole Spray Dried Dispersion Utilizing Design of Experiment As An Optimization Strategy

    Solid dispersion (SD) technology is one of the most widely preferred solubility enhancement methods, especially for Biopharmaceutics classification...

    Kaushika Patel, Jaymin Patel, Shreeraj Shah in AAPS PharmSciTech
    Article 12 September 2023
  5. Application of Amorphous Solid Dispersion Technology for Improving the Physicochemical Properties, Saturation Solubility, and In Vitro Dissolution of Withania somnifera Methanolic Root Powder Extract

    Purpose

    Withania somnifera is a xerophytic plant whose methanolic extract of root powder has exhibited effectiveness against various diseases. Like...

    Kiran Dudhat, Monika Bhalodiya, ... Mori Dhaval in Journal of Pharmaceutical Innovation
    Article 05 April 2023
  6. Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid–base neutralization approach

    “Brick dust” compounds have high lattice energy as manifested by the poor aqueous solubility and suboptimal bioavailability. Nilotinib being a weakly...

    Mahendra Chougule, Arvind Sirvi, ... Abhay T. Sangamwar in Drug Delivery and Translational Research
    Article 06 April 2023
  7. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets

    An amorphous solid dispersion (ASD) is a commonly used approach to enhancing the dissolution of poorly aqueous soluble drugs. Selecting the desired...

    Dongyue Yu, Frederick Fiddler, ... Stephen W. Hoag in AAPS PharmSciTech
    Article 17 October 2022
  8. Dissolution Kinetics of Nifedipine—Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers

    Purpose

    The intestinal fluid pH is maintained by the bicarbonate buffer system that shows unique properties regarding drug dissolution. Nevertheless,...

    Aoi Sakamoto, Kiyohiko Sugano in Pharmaceutical Research
    Article 20 December 2021
  9. Preparation and Characterization of Ibrutinib Amorphous Solid Dispersions: a Discussion of Interaction Force

    The aim of this study was to improve the solubility and dissolution of Ibrutinib (IBR), a biopharmaceutical classification system (BCS) class II...

    **angjun Shi, Baibai Fan, ... Yu Deng in Journal of Pharmaceutical Innovation
    Article 30 September 2021
  10. Design and Characterization of HY-038 Solid Dispersions via Spray Drying Technology: In Vitro and In Vivo Evaluations

    The aim of this study was to prepare HY-038 solid dispersions (SDs) with single carrier at high drug loading and then forming a tablet to enhance...

    Taotao Jiang, Limei Han, ... **anyi Sha in AAPS PharmSciTech
    Article 08 November 2021
  11. Preparation and Characterization of a Lutein Solid Dispersion to Improve Its Solubility and Stability

    Lutein has been used as a dietary supplement for the treatment of eye diseases, especially age-related macular degeneration. For oral formulations,...

    Chaemin Lim, ** Kook Kang, ... Kyung Taek Oh in AAPS PharmSciTech
    Article 02 June 2021
  12. Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale

    Spray-drying dispersion (SDD) is a well-established manufacturing technique used to prepare amorphous solid dispersions (ASDs), allowing for poorly...

    Marika Nespi, Robert Kuhn, ... Dennis Leung in AAPS PharmSciTech
    Article 20 December 2021
  13. Effects of Additives on the Physical Stability and Dissolution of Polymeric Amorphous Solid Dispersions: a Review

    Polymeric amorphous solid dispersion (ASD) is a popular approach for enhancing the solubility of poorly water-soluble drugs. However, achieving both...

    **ghan Li, Yihan Wang, Dongyue Yu in AAPS PharmSciTech
    Article 21 August 2023
  14. Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions

    The success of obtaining solid dispersions for solubility improvement invariably depends on the miscibility of the drug and polymeric carriers. This...

    Guilherme G. Moreira, Stephânia F. Taveira, ... Ricardo N. Marreto in AAPS PharmSciTech
    Article 06 June 2024
  15. Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison

    Galeterone, a novel prostate cancer candidate treatment, was discontinued after a Phase III clinical trial due to lack of efficacy. Galeterone is...

    Stephen A. Thompson, Urvi Gala, ... Robert O. Williams III in AAPS PharmSciTech
    Article 21 June 2023
  16. Microfluidics-on-a-chip for designing celecoxib-based amorphous solid dispersions: when the process shapes the product

    The fundamental idea underlying the use of amorphous solid dispersions (ASDs) is to make the most of the solubility advantage of the amorphous form...

    Joana Figueiredo, Maria Mendes, ... Carla Vitorino in Drug Delivery and Translational Research
    Article Open access 11 June 2024
  17. The Development of a Novel Pharmaceutical Formulation of D-Tagatose for Spray-Drying

    Purpose

    D-tagatose is an alternative sweetener with superior properties for reducing overall sugar absorption, which is especially important in the...

    Heather R. Campbell, Fahd M. Alsharif, ... Robert A. Lodder in Journal of Pharmaceutical Innovation
    Article 16 October 2020
  18. Enlarged pore of worm mesoporous silica nanoparticles improves anti-inflammatory drug absorption

    Searching for an effective pore-enlarging agent to form mesoporous silica nanoparticles (MSN) with a creative surface frame is of great importance....

    Yuying Ou, Demiao Zhu in Drug Delivery and Translational Research
    Article 20 March 2023
  19. Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant

    Background and Objectives

    The potent, selective P2X3 receptor antagonist eliapixant (BAY 1817080) is under development for conditions characterized by...

    Klaus Francke, Niladri Chattopadhyay, ... Christian Friedrich in European Journal of Drug Metabolism and Pharmacokinetics
    Article 05 December 2022
  20. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole

    Among the great number of poorly soluble drugs in pharmaceutical development, most of them are weak bases. Typically, they readily dissolve in an...

    Marius Monschke, Kevin Kayser, Karl G. Wagner in AAPS PharmSciTech
    Article Open access 12 January 2021
Did you find what you were looking for? Share feedback.